Oct. 19 at 12:06 PM
$SSKN Buy value. Strata is trading at .03x current sales. Most medical device companies trade at 3x sales. Do the math. SSKN is undervalued. Should be 90mil on market cap. That would be
$17/share. Once CMS updates the CPT codes revenue should get closer to 50mil per year. At 3x 50mil in sales price per share would be
$28. Seemingly far off, but that is the math.